Michael Geffner - 24 Apr 2024 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Reporting relationship: Chief Medical Officer
Issuer ticker: IMVT
Reported as of: 24 Apr 2024
Net transaction value: -$94,243
SEC form: 4
Accepted by SEC: 26 Apr 2024, 17:22:51 UTC
Prior SEC filing: 04 Apr 2024
Next SEC filing: 26 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Eva Renee Barnett, attorney-in-fact for Michael Geffner

Key filing fact

Michael Geffner filed Form 4 for Immunovant, Inc. (IMVT) on 26 Apr 2024.

Key facts

This page summarizes Michael Geffner's Form 4 filing for Immunovant, Inc. (IMVT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Apr 2024, 17:22.

Change

Previous filing in this sequence was filed on 04 Apr 2024.
Current net transaction value: -$94,243.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMVT transaction

Common Stock

Sale

Transaction value: $94,243
Shares: -3,261
Change %: -2.3%
Price: $28.90
Shares after: 141,616
Date: 24 Apr 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On January 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 3 filed on January 16, 2024, of which 6,250 of these RSUs vested on April 17, 2024. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.